PTGX SG&A Expense Growth
Protagonist Therapeutics Inc · SG&A Expense Growth
PTGX SG&A Expense Growth
Latest reported3.20%period ending
PTGX FY SG&A Growth (YoY) (0.00% → 3.20%)
Latest values, visible window
High-resolution chart · PNG
PTGX sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 3.2005% | |
| 29.7722% | |
| 5.52% | |
| 16.7047% | |
| 45.9169% | |
| 18.344% | |
| 14.9814% | |
| 16.2832% | |
| 69.2142% | |
| 134.9308% | |
| 59.3011% | |
| 0% |